Dong Sung Bio Pharm.Co.,Ltd. (002210.KS)
KRW 5320.0
(1.92%)
KRW 5320.0
(1.92%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 88.59 Billion | 93.32 Billion | 84.4 Billion | 87.79 Billion | 86.53 Billion | 91.91 Billion |
| Cost of Revenue | 47.94 Billion | 51.27 Billion | 50.86 Billion | 53.65 Billion | 53.46 Billion | 56.71 Billion |
| Gross Profit | 40.64 Billion | 42.05 Billion | 33.54 Billion | 34.14 Billion | 33.07 Billion | 35.19 Billion |
| Operating Expenses | 40.05 Billion | 45.15 Billion | 38.84 Billion | 37.81 Billion | 40.6 Billion | 37 Billion |
| Selling, General and Administrative Expenses | 26.65 Billion | 28.83 Billion | 23.08 Billion | 23.45 Billion | 23.68 Billion | 21.15 Billion |
| Research and Development Expenses | 4.16 Billion | 4.11 Billion | 3.39 Billion | 3.37 Billion | 3.1 Billion | 3 Billion |
| Other Expenses | 9.94 Billion | 12.2 Billion | 12.36 Billion | 10.99 Billion | 13.82 Billion | 243.47 Million |
| Cost and Expenses | 87.99 Billion | 96.42 Billion | 89.7 Billion | 91.47 Billion | 94.06 Billion | 93.71 Billion |
| Operating Income | 596.4 Million | -2.04 Billion | -5.29 Billion | -3.67 Billion | -7.53 Billion | -1.8 Billion |
| Interest Expense | 2.24 Billion | 1.3 Billion | 712.2 Million | 850.3 Million | 1.4 Billion | 1.68 Billion |
| Income Tax Expense | 1.2 Billion | 271.06 Million | -66.5 Million | 3.27 Billion | -380.34 Million | -948.52 Million |
| Earnings before Tax | -865.88 Million | -1.85 Billion | -4.37 Billion | -10.8 Billion | -8.76 Billion | -6.69 Billion |
| Net Income | -2.07 Billion | -2.12 Billion | -4.31 Billion | -14.07 Billion | -8.38 Billion | -5.74 Billion |
| Earnings Per Share Basic | -90.70 | -92.23 | -184.52 | -599.87 | -363.57 | -293.00 |
| Earnings Per Share Diluted | -86.74 | -87.74 | -184.29 | -599.87 | -363.57 | -293.00 |
| Weighted Average Shares Outstanding | 22.86 Million | 23 Million | 23.37 Million | 23.47 Million | 23.06 Million | 19.6 Million |
| Weighted Average Shares Outstanding (Diluted) | 23.91 Million | 24.18 Million | 23.4 Million | 23.47 Million | 23.06 Million | 19.6 Million |
| Gross Margin | 0.46 | 0.45 | 0.40 | 0.39 | 0.38 | 0.38 |
| EBIT Margin | 0.04 | 0.00 | -0.02 | -0.02 | -0.05 | 0.01 |
| Profit Margin | -0.02 | -0.02 | -0.05 | -0.16 | -0.10 | -0.06 |
| EBITDA | 3.42 Billion | 1.52 Billion | -1.73 Billion | -8.14 Billion | -5.32 Billion | -3.08 Billion |
| Earnings Before Tax Margin | 0.01 | -0.02 | -0.06 | -0.04 | -0.09 | -0.02 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 21.74 Billion | 22.7 Billion | 21.73 Billion | 88.59 Billion | 22.04 Billion | 23.35 Billion |
| Cost of Revenue | 12.61 Billion | 12.49 Billion | 12.51 Billion | 47.94 Billion | 10.9 Billion | 12.69 Billion |
| Gross Profit | 9.12 Billion | 10.21 Billion | 9.22 Billion | 40.64 Billion | 11.14 Billion | 10.66 Billion |
| Operating Expenses | 11.11 Billion | 10.1 Billion | 9.86 Billion | 40.05 Billion | -10.94 Billion | 10.52 Billion |
| Selling, General and Administrative Expenses | 9.9 Billion | 9.03 Billion | 8.78 Billion | - | 10.94 Billion | 6.7 Billion |
| Research and Development Expenses | 1.2 Billion | 1.05 Billion | 1.01 Billion | - | 940.77 Million | 1.14 Billion |
| Other Expenses | -17.16 Million | -15.98 Million | -59.61 Million | -220.99 Million | -21.88 Billion | 224.24 Million |
| Cost and Expenses | 23.73 Billion | 22.6 Billion | 22.38 Billion | 87.99 Billion | 10.9 Billion | 23.22 Billion |
| Operating Income | -1.99 Billion | 105.45 Million | -641.85 Million | 596.4 Million | 204.86 Million | 136.44 Million |
| Interest Expense | 708.28 Million | 612.99 Million | 667.53 Million | 2.24 Billion | 593.05 Million | 504.51 Million |
| Income Tax Expense | 218.96 Million | -42.53 Million | 1.22 Billion | 1.2 Billion | -947.12 Million | 720.35 Million |
| Earnings before Tax | -841.01 Million | -205.92 Million | -758.87 Million | -865.88 Million | -991.78 Million | -92.51 Million |
| Net Income | -1.05 Billion | -163.39 Million | -1.98 Billion | -2.07 Billion | -44.65 Million | -812.87 Million |
| Earnings Per Share Basic | -46.36 | -7.15 | -86.94 | - | -1.95 | -35.55 |
| Earnings Per Share Diluted | -46.36 | -7.15 | -83.00 | - | -1.95 | -35.55 |
| Weighted Average Shares Outstanding | 22.86 Million | 22.86 Million | 22.86 Million | 22.86 Million | 22.86 Million | 22.86 Million |
| Weighted Average Shares Outstanding (Diluted) | 22.86 Million | 22.86 Million | 23.95 Million | 23.91 Million | 22.86 Million | 22.86 Million |
| Gross Margin | 0.42 | 0.45 | 0.42 | 0.46 | 0.51 | 0.46 |
| EBIT Margin | -0.07 | 0.03 | -0.01 | - | 0.51 | 0.03 |
| Profit Margin | -0.05 | -0.01 | -0.09 | -0.02 | -0.00 | -0.03 |
| EBITDA | -1.47 Billion | 596.21 Million | -116.61 Million | - | 11.14 Billion | 673.93 Million |
| Earnings Before Tax Margin | -0.09 | 0.00 | -0.03 | 0.01 | 0.01 | 0.01 |
023530
6919
QMCQF
HTHIF
4890
023410